chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Nausea, Pyrexia, Swollen tongue
Clinical narrative: Tongue swelling; Headache; Nausea; Tired; Chills; Muscle weakness; Fever 100.5; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid polyarthritis, inflammatory polyarthritis, graves disease and allergy to bee stings and contrast dye. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN) dose of 20mg weekly and thiamazole (METHIMAZOLE) dose of 7.5 mg daily; both for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation and codeine for unknown indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in 2021 after second dose of vaccination, the patient experienced tongue swelling, headache, nausea, tired, chills, muscle weakness, fever 100.5 and joint pain. On an unknown date, the body temperature was reported as 100.5 (unit unspecified). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events tongue swelling, headache, nausea, tired, chills, muscle weakness, fever and joint pain was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 30Mar2021 at 10:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not allergic to medications, food or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 09Mar2021 at 10:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, the patient underwent a Nasal Swab test (colour anterior nares PCR Test) and the result was found to be Negative. On 01Apr2021 at 18:30, the patient experienced Axillary adenopathy - swollen lymph tissue across left underarm. The patient did not receive any treatment for the reported event. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome for the event axillary adenopathy was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral
Clinical narrative: I had tingling sensation on my left cheek, back of my neck, around my mouth and hands and feet; I had tingling sensation on my left cheek, back of my neck, around my mouth and hands and feet; This is a spontaneous report from a contactable other healthcare professional, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 12Mar2021 at 08:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies. The patient had allergies to penicillin, latex, environmental, wheat and a few others. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021, the patient experienced tingling sensation on left cheek, back of neck, around mouth and hands and feet, which lasted almost until second dose. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event tingling sensation on left cheek, back of neck, around mouth, hands and feet was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity
Clinical narrative: Headache; Chills; Sore arm; This is a spontaneous report from a contactable healthcare professional, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CCDPH/VW) via an unspecified route of administration on an unknown date (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date, the patient experienced headache, chills and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events headache, chills and sore arm. The clinical outcome of the events headache, chills and sore arm were resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Neck pain, Ocular discomfort, Paraesthesia
Clinical narrative: Sore neck; dizziness; pins and needles feeling while standing; Pressure feeling behind eyes; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 02Apr2021 at 14:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and COVID-19. Concomitant medications included valproate semisodium (DEPAKOTE ER) from an unknown date, for an unknown indication. The patient previously took Lamictal and experienced allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 03:00 the patient experienced sore neck, dizziness, pins and needles feeling while standing and pressure feeling behind eyes.  The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of sore neck, dizziness, pins and needles feeling while standing and pressure feeling behind eyes was recovering at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia
Clinical narrative: fatigue; chills; muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's thyroiditis. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 25Mar2021 at 12:00  the patient experienced fatigue, chills and muscle aches. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, chills and muscle aches were recovered on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Bad headache; chills; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included sarcoidosis, asthma, morphea, migraines and obesity. The patient had no allergies to medications, food, or other products. Concomitant medications within two weeks of vaccination included vitamins (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE), chondroitin (MANUFACTURER UNKNOWN), glucosamine (MANUFACTURER UNKNOWN), all taken from unknown dates for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, 24 hours after the vaccination, the patient experienced chills and fatigue which lasted for 24 hours. On 22Mar2021, 72 hours after the vaccination, the patient experienced bad headache which lasted for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chills and fatigue was resolved on 21Mar2021, while that of bad headache was resolved on 25Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: I am unable to lift my arm above my shoulder without severe muscle pain in my upper arm.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the arm left on 10Feb2021 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. The patient received unspecified medication within two weeks of vaccination. The patient previously took diclofenac (VOLTAREN) on unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021, the patient experienced inability to lift her arm above shoulder without severe muscle pain in the upper arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse event and included treatment with prednisone for 7 days. The clinical outcome of the event inability to lift arm above shoulder without severe muscle pain in the upper arm was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fever; Headache; Muscle and joint pain; Joint pain; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 01Apr2021 at 11:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS) and COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received sulfonamide (MANUFACTURER UNKNOWN) drugs, and penicillin (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 10:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01Apr2021 at 19:00, the patient experienced fever, headache, fatigue, muscle and joint pain. The adverse event did not result in doctor or other healthcare professional office/clinic or emergency room visit. The patient did not receive any treatment for the events. The clinical outcome of the events fever, headache, fatigue, muscle and joint pain were recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed shingles on right axilla and down the arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7534) via an unspecified route of administration in the left arm on 16Mar2021 at 23:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient did not receive any medications within two weeks of COVID-19 vaccination. On 24Mar2021 at 08:00 the patient experienced shingles on right axilla and down the arm. Therapeutic measures were taken as a result of shingles and included treatment with VALTREX given 3 times a day for 1 week. The adverse event resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the event shingles on right axilla and down the arm was recovered on unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: foggy headed; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 00:45 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to something that starts with p that prevents itching, but it was unspecified. Concomitant medications included propranolol (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and b. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 06Mar2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 15:30, the patient felt extremely foggy-headed all day. It was like her brain was in the off-position. The patient needed to drop-off her GPS at a store five miles away to have it updated. While driving there, she completely forgot where she was going four times, & it took a while for it to come back to her. The patient couldn't think at all, she just had to wait for it to come to her, and she was calmly driving down a 2-lane road the first time, the patient knew she was going in the right direction, but couldn't remember where she was supposed to end up. That happened twice on that one & a half mile stretch of road. Then while her brain was working, the patient got on a major highway and did that two more times, she completely forgot where the heck she was going (not a clue). The patient just kept driving, calmly, and finally, the business popped into her brain, and she was satisfied, and she just kept going till she got to her exit then she got off the highway and found the business. The patient had forgotten where she was going before, but never 4 times in one trip. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event foggy feeling in head was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, SARS-CoV-2 test, Vaccination site pain, Vaccination site warmth
Clinical narrative: Non-stop hot flashes (day and night) since the jab; Headache; Warmth  at the injection site; Soreness at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 52-yeasr-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the arm left on 20Mar2021 at 15:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The concomitant medication were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 25Sep2020, the patient underwent COVID test (nasal swab test) and resulted negative. On 17Dec2020, the patient underwent COVID test (nasal swab test) and resulted negative. Since the vaccination, on an unknown date in 2021, the patient had been tested for COVID-19 and result was unknown. On 20Mar2021 the patient experienced non-stop hot flashes (day and night) since the jab, headache on the day of the vaccine, warmth and soreness at the injection site for a couple days. Therapeutic measures and treatments were not taken as a result of reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events hot flashes, headache, warmth and soreness were not recovered. at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Tremor
Clinical narrative: lightheaded; muscles shaky; nauseous; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737) via an unspecified route of administration, in the left arm on 03Apr2021 at 12:45 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included bisoprolol fumarate (ZEBETA), escitalopram oxalate (LEXAPRO), atorvastatin calcium (LIPITOR), buspirone hydrochloride (BUSPAR) and hydrochlorothiazide (MANUFACTURER UNKNOWN), all for unknown indications  from unknown dates. The patient previously received epinephrine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 03Apr2021 at 12:45, five seconds after vaccination, the patient felt lightheaded, muscles were shaky and nauseous. Felt this intensely for two hours and then it lessened but still felt sick. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the events of lightheaded, tremor muscle and nausea were recovered with sequelae on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inflammation, Psoriasis
Clinical narrative: Headache; overall inflammation; psoriasis flare; This is a spontaneous report from a contactable healthcare professional, the patient. A 38-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730), via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included psoriasis, Hashimoto's, irritable bowel syndrome with constipation (reported as IBS-C), polycystic ovarian syndrome (reported as PCOS) and menstrual migraine. The patient was allergic to papaya and milk. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN) and magnesium citrate (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021, approximately 48 hours after vaccination, the patient experienced headache, overall inflammation and psoriasis flare. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the event headache, inflammation and psoriasis flare was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes on collar bone and under under.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 01Apr2021 at 11:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 10Mar2021 at 16:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 14:00, the patient experienced swollen lymph nodes on collar bone on left side and reportedly under under. The patient had lymphadenopathy on the same side as the vaccine administered. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event swollen lymph nodes on collar bone was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, SARS-CoV-2 test
Clinical narrative: Dots on  chest. Skin was completely smooth. It appears to be under the skin.; Small, tiny, reddish/purplish dots. Those appeared 1-2 days after 1st vaccine shot on arms (forearms + near elbow crease).; This is a spontaneous report from a contactable consumer, the patient. A 28-years-old non pregnant female patient received a first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in left arm on 30Mar2021 at 14:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included HIV (but undetectable). The patient had no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not been diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19. On 31Mar2021,after getting first vaccination shot the patient had experienced rash erythematous and rash on chest. (Patient had small, tiny, reddish/purplish dots which were appeared 1-2 days after her 1st vaccine shot on her arms (forearms + near elbow crease), then those went away. The patient had noticed the same dots on patient chest later. patient skin was completely smooth and the rashes were appeared to be under the skin). The patient underwent lab tests and procedures which included SARS-CoV-2 test on 31Mar2021 and was tested negative. No therapeutic measures were taken as the result of adverse events. The clinical outcome of the events rash erythematous and rash were not recovered.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Fatigue, Nausea, Pain
Clinical narrative: tiredness; soreness; nausea; Extremely painful, sharp pain in center/right side of chest; Extremely painful, sharp pain in center/right side of chest and upper back (between shoulder blades).; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 01Apr2021 at 10:00 (at the age of 40-year-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, left kidney and appendix removed in 1982 due to cancer. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), paracetamol (TYLENOL) and cetirizine hydrochloride (ZYRTEC) from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 08Mar2021 at 12:00 (at the age of 40-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 02Apr2021, the patient experienced extremely painful, sharp pain in center/right side of chest and upper back (between shoulder blades) that came and went in waves for about three hours, 14-17 hours after the vaccine. On 02Apr2021 at 17:45, the patient also experienced more normal reaction of tiredness, soreness and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events extremely painful, sharp pain in center/right side of chest and upper back (between shoulder blades) was resolved on 02Apr2021 while that of the events tiredness, soreness and nausea were resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia
Clinical narrative: Very very Tired.; Approx. 11 hours of sleep; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 20Mar2021 at 11:00 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19, pneumonia and minor case of epilepsy. The patient did not have any allergies to medications, food or other products. Concomitant medications included carbamazepine (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Mar2021, the patient experienced very very tired and would go to bed as soon as got home from work, and slept until got up the next day for work. Approx. 11 hours of sleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events very very tired and would go to bed as soon as got home from work, and slept until got up the next day for work were resolved on 28Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Nausea, Pain, Vaccination site pain
Clinical narrative: Depression; Body aches; Ache at the site of injection; Mild nausea; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm right on 13Mar2021 at 09:45 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included breast feeding. It was reported that breastfeeding could be considered chronic and the patient was an abnormally healthy person, doesn't get sick often. Concomitant medications included prenatal vitamins(MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6208) via an unspecified route of administration in the arm left on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 10:00, 15 minutes after vaccination, the patient experienced depression, general body pain, vaccination site pain and nausea. The patient had depression, body aches, ache at the site of injection and mild nausea. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events depression, general body pain, vaccination site pain and nausea were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Joint stiffness, Musculoskeletal stiffness, Peripheral swelling, Vaccination site swelling
Clinical narrative: Swelling of arm; Swelling to upper arm around injection site; Stiffness of joints; Stiffness of joints especially neck; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 20:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and depression. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received penicillin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 03Apr2021 at 17:00, 18 hours after the injection, the patient experienced prolonged, extensive swelling to upper arm around injection site and stiffness of joints, especially neck intensifying with swelling of arm. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events was swelling of arm, vaccination site swelling, joint stiffness and neck stiffness and were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Malaise, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Unable to bend or move fingers without pain throughout arm and fingers; chills; unable to sleep due to pain; Felt unwell; headaches; Unable to bend or move fingers without pain throughout arm and fingers; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955), via an unspecified route of administration in the left arm on 02Apr2021 at 13:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medications included ethinylestradiol, norgestimate (SPRINTEC) and cetirizine hydrochloride (ZYRTEC), all for unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 09:00, the patient was unable to bend or move fingers without pain throughout arm and fingers along with chills next morning; and only then, about 09:00 to 17:00 (woke up every 30-40 minutes) was unable to sleep due to pain. After felt unwell, headaches, pain throughout arm and underarm when awake. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of unable to bend or move fingers without pain throughout arm and fingers, chills, unable to sleep due to pain, felt unwell and headache were recovering.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Poor quality sleep
Clinical narrative: Unable to bend or move fingers without pain throughout arm and fingers; chills; unable to sleep due to pain; Felt unwell; headaches; Unable to bend or move fingers without pain throughout arm and fingers; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955), via an unspecified route of administration in the left arm on 02Apr2021 at 13:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medications included ethinylestradiol, norgestimate (SPRINTEC) and cetirizine hydrochloride (ZYRTEC), all for unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 09:00, the patient was unable to bend or move fingers without pain throughout arm and fingers along with chills next morning; and only then, about 09:00 to 17:00 (woke up every 30-40 minutes) was unable to sleep due to pain. After felt unwell, headaches, pain throughout arm and underarm when awake. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of unable to bend or move fingers without pain throughout arm and fingers, chills, unable to sleep due to pain, felt unwell and headache were recovering.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Livedo reticularis, Oral pruritus, Paraesthesia, Urticaria
Clinical narrative: arm became very mottled black & blue marks appeared on back of upper arm also back of the hand and raised hive; my arm became very mottled black & blue marks appeared on back of upper arm also back of the hand and raised hive; Tingling around mouth ears scalp and face; Tightness in chest; Itching around lower mouth area; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO151) via an unspecified route of administration in the left arm on 31Mar2021 at 13:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and stroke. Concomitant medications included enalapril (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and clopidogrel (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The patient had known allergies (unspecified) to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:45, the patient arm became very mottled, black and blue marks appeared on back of upper arm also back of the hand and raised hive; had tingling around mouth, ears, scalp and face; tightness in chest and itching around lower mouth area. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events mottled skin, hives, tingling around mouth, ears, scalp and face, tightness in chest and itching around lower mouth area was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Pain
Clinical narrative: Swollen lymph nodes; Chills; Aches; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 02Apr2021 at 09:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. The patient had no known allergies to medications, food or other products. Concomitant medications included curcuma longa (TURMERIC), fish oil (MANUFACTURER UNKNOWN) and loratadine (CLARITIN), all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 12Mar2021 at 10:00 (at the age 45-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021, the patient experienced swollen lymph nodes, aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of swollen lymph nodes, ache, and chills was not resolved at the time of the report.  No follow-up attempts are needed; information about lot/ batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Vaccination site erythema
Clinical narrative: itchy rash at the vaccination site; red rash at vaccination site; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 01Apr2021 at 18:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease and ocular myasthenia. The patient was allergic to iodinated contrast dye. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN); both from an unknown date, for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6208) via an unspecified route of administration in the left arm on 11Mar2021 at 18:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 the patient experienced itchy red rash after 48hours of vaccination at the vaccination site. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient received antihistamines as a treatment for the adverse events. The clinical outcome of the event itchy red rash at the vaccination site was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Migraine, Petechiae, Vaccination site erythema, Vaccination site pain
Clinical narrative: Petechia; Severe migraine; Numbness in the right leg; the site where the shot was done was red and tender; the site where the shot was done was red and tender; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 07:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included heartburn. Concomitant medications included unspecified birth control medication, multivitamin (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and iron (MANUFACTURER UNKNOWN), all taken for unknown indications from unknown dates. The patient previously received sulfamethoxazole/trimethoprim (BACTRIM) and influenza vaccine (flu shot) (MANUFACTURER UNKNOWN) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Apr2021 at 08:00 (reported as of today), the site where the shot was done was red and tender. She had a severe migraine on Friday and also had numbness in the right leg. She had petechia and those spots had increased. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events the site where the shot was done is red and tender, severe migraine, numbness in the right leg and petechia. The clinical outcome of the events the site where the shot was done is red and tender, severe migraine, numbness in the right leg and petechia were resolving at the time of the report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Myalgia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 31Mar2021 at 18:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, aortic valve replacement and allergy to statins. Concomitant medications include metoprolol (MANUFACTURER UNKNOWN), desipramine (MANUFACTURER UNKNOWN), esomeprazole magnesium (NEXIUM), ezetimibe (MANUFACTURER UNKNOWN) and acetyl salicylic acid (ASPRIN). The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 15:00, the patient experienced severe headache, muscle aches, chills, sweats and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events severe headache, muscle aches, chills, sweats and fatigue were resolving at the time of report. No follow-up attempts are needed. No further information is expected.